Health&Beauty- Page 108

The FINANCIAL -- Pfizer announced that it has received the 2011 Business Civic Leadership Center’s Corporate Citizenship Award in the Best International Ambassador category for Pfizer’s Global Health Partnerships program.

The FINANCIAL -- Pfizer announced that its Market Authorisation Application for tofacitinib, a novel, oral JAK inhibitor being studied for the treatment of moderate-to-severe active rheumatoid arthritis , has been validated by the European Medicines Agency.

The FINANCIAL -- Bayer HealthCare’s collaboration partner, Regeneron Pharmaceuticals has received approval from the U.S. Food and Drug Administration for EYLEA Injection, known in the scientific literature as VEGF Trap-Eye, for the treatment of patients with neovascular age-related macular degeneration at a

The FINANCIAL -- Females are seven to nine times more likely to suffer “broken heart syndrome,” when sudden or prolonged stress like an emotional breakup or death causes overwhelming heart failure or heart attack-like symptoms, the first nationwide study of this finds.